Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions for the life sciences industry, and Sanofi Vaccines are leveraging Medidata eCOA to We announced that we will collaborate to advance vaccine research. This is based on Medidata and Sanofi’s long experience with Medidata Rave EDC (electronic data capture).
In this collaboration, an eDiary library specialized for Sanofi’s vaccines will be built using eCOA’s eDiary function. This library will reduce setup time for future trials, increase efficiency, improve data quality, and ensure patient access to an easy-to-use eDiary.
Sanofi’s decision to utilize eCOA’s capabilities in its vaccine trials reduces on-site monitoring and allows patients to enter real-time data no matter where they are, allowing patients to spend more time in trials. It made my days more ideal. During the pilot phase, eCOA was used in six vaccine trials, with high levels of patient compliance and reliable data. In response, the use of eCOA has moved beyond the pilot phase and is being rolled out across Sanofi’s vaccine clinical trial pipeline.
Also Read : Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer
said Global Head of Clinical Data Management, Sanofi Vaccines. “By expanding our collaboration with Medidata, we can improve the clinical development process to bring breakthrough vaccines to patients. Leveraging our bespoke eDiary library, we have optimized our eDiary setup and This will improve data quality in clinical trials and further advance the digital era in the pharmaceutical industry.”
Anthony Costello, Chief Executive Officer of Medidata Patient Cloud, said: “At Medidata, we put patients at the center of everything we do, and working with Sanofi, who shares this philosophy, will improve the patient experience, improve patient monitoring in current research, and improve future patient outcomes.” It helps accelerate research timelines and efficiency.”
SUORCE : Businesswire